Video: 2022 M&A Transactional Outlook Part 2

Andre Ulloa provides the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.


More From M&A Healthcare Advisors

Understanding Working Capital and the True-Up Process in Healthcare M&A
How to Prepare for Buyer Diligence: A Checklist for Healthcare Operators
Understanding Working Capital and the True-Up Process in Healthcare M&A
Strategic vs. Financial Buyers: What’s the Difference and Why It Matters
Understanding Working Capital and the True-Up Process in Healthcare M&A
Enhancing Enterprise Value: The Uses of a Quality of Earnings (QoE) Analysis for Maturing Businesses
{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350